Visualitza per autor "Morgades, Mireia"
Ara mostrant els elements 1-5 d 5
-
A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: results of the ALLRE08 PETHEMA trial
Ribera, Josep-Maria; Tormo, Mar; Martínez-Carballeira, Daniel; González-Campos, José; Barba Suñol, Pere; Montesinos, Pau; Morgades, Mireia (Wiley, 2020-04) -
Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)
Genescà, Eulàlia; González Gil, Celia; Fuster-Tormo, Francisco; Haferlach, Claudia; Meggendorfer, Manja; Barba Suñol, Pere; Morgades, Mireia (Elsevier, 2021-10) -
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial
Ribera Santasusana, Josep Maria; Morgades, Mireia; Garcia-Calduch, Olga; Sirvent, Maialen; Buendia, Buenaventura; Cervera, Marta; Abrisqueta, Pau (Ferrata Storti Foundation, 2024-02) -
Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials
González Gil, Celia; Lopes, Thaysa Fedalto; Fuster-Tormo, Francisco; García-Chica, Jesús; Zhao, Ran; Barba Suñol, Pere; Morgades, Mireia (Ferrata Storti Foundation, 2023-04) -
Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocols
Ribera, Jordi; Granada, Isabel; González, Teresa; Ciudad, Juana; Such, Esperanza; Barba Suñol, Pere; Morgades, Mireia (Wiley, 2022-02)